Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yosuke Mizuno is active.

Publication


Featured researches published by Yosuke Mizuno.


Biochemical and Biophysical Research Communications | 2008

miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation.

Yosuke Mizuno; Ken Yagi; Yoshimi Tokuzawa; Yukiko Kanesaki-Yatsuka; Tatsuo Suda; Takenobu Katagiri; Toru Fukuda; Masayoshi Maruyama; Akihiko Okuda; Tomoyuki Amemiya; Yasumitsu Kondoh; Hideo Tashiro; Yasushi Okazaki

Although various microRNAs regulate cell differentiation and proliferation, no miRNA has been reported so far to play an important role in the regulation of osteoblast differentiation. Here we describe the role of miR-125b in osteoblastic differentiation in mouse mesenchymal stem cells, ST2, by regulating cell proliferation. The expression of miR-125b was time-dependently increased in ST2 cells, and the increase in miR-125b expression was attenuated in osteoblastic-differentiated ST2 cells induced by BMP-4. The transfection of exogenous miR-125b inhibited proliferation of ST2 cells and caused inhibition of osteoblastic differentiation. In contrast, when the endogenous miR-125b was blocked by transfection of its antisense RNA molecule, alkaline phosphatase activity after BMP-4 treatment was elevated. These results strongly suggest that miR-125b is involved in osteoblastic differentiation through the regulation of cell proliferation.


FEBS Letters | 2009

miR‐210 promotes osteoblastic differentiation through inhibition of AcvR1b

Yosuke Mizuno; Yoshimi Tokuzawa; Yuichi Ninomiya; Ken Yagi; Yukiko Yatsuka-Kanesaki; Tatsuo Suda; Toru Fukuda; Takenobu Katagiri; Yasumitsu Kondoh; Tomoyuki Amemiya; Hideo Tashiro; Yasushi Okazaki

Although microRNAs (miRNAs) are involved in many biological processes, the mechanisms whereby miRNAs regulate osteoblastic differentiation are poorly understood. Here, we found that BMP‐4‐induced osteoblastic differentiation of bone marrow‐derived ST2 stromal cells was promoted and repressed after transfection of sense and antisense miR‐210, respectively. A reporter assay demonstrated that the activin A receptor type 1B (AcvR1b) gene was a target for miR‐210. Furthermore, inhibition of transforming growth factor‐β (TGF‐β)/activin signaling in ST2 cells with SB431542 promoted osteoblastic differentiation. We conclude that miR‐210 acts as a positive regulator of osteoblastic differentiation by inhibiting the TGF‐β/activin signaling pathway through inhibition of AcvR1b.


Journal of Immunology | 2008

B Cell Chemoattractant CXCL13 Is Preferentially Expressed by Human Th17 Cell Clones

Rie Takagi; Takehiro Higashi; Kumiko Hashimoto; Kazuhisa Nakano; Yosuke Mizuno; Yasushi Okazaki; Sho Matsushita

Th 17 cells represent a novel subset of CD4+ T cells that have a protective effect against extracellular microbes, while they are also responsible for autoimmune disorders in mice. However, the protein expression profile of Th17 cells remains to be clarified. In this study, we report an effective method to establish human allo-reactive Th17 cell clones and demonstrate that human Th17, but not Th1 or Th2, cells express B cell chemoattractant CXCL13, by using DNA chips, RT-PCR, and ELISA. Such a pattern was also the case in Candida albicans-specific Th17 clones and synovial fluid specimens obtained from patients with rheumatoid arthritis. The biological implication of this finding is discussed.


PLOS Genetics | 2016

A Comprehensive Genomic Analysis Reveals the Genetic Landscape of Mitochondrial Respiratory Chain Complex Deficiencies

Masakazu Kohda; Yoshimi Tokuzawa; Yoshihito Kishita; Hiromi Nyuzuki; Yohsuke Moriyama; Yosuke Mizuno; Tomoko Hirata; Yukiko Yatsuka; Yzumi Yamashita-Sugahara; Yutaka Nakachi; Hidemasa Kato; Akihiko Okuda; Shunsuke Tamaru; Nurun Nahar Borna; Kengo Banshoya; Toshiro Aigaki; Yukiko Sato-Miyata; Kohei Ohnuma; Tsutomu Suzuki; Asuteka Nagao; Hazuki Maehata; Fumihiko Matsuda; Koichiro Higasa; Masao Nagasaki; Jun Yasuda; Masayuki Yamamoto; Takuya Fushimi; Masaru Shimura; Keiko Kaiho-Ichimoto; Hiroko Harashima

Mitochondrial disorders have the highest incidence among congenital metabolic disorders characterized by biochemical respiratory chain complex deficiencies. It occurs at a rate of 1 in 5,000 births, and has phenotypic and genetic heterogeneity. Mutations in about 1,500 nuclear encoded mitochondrial proteins may cause mitochondrial dysfunction of energy production and mitochondrial disorders. More than 250 genes that cause mitochondrial disorders have been reported to date. However exact genetic diagnosis for patients still remained largely unknown. To reveal this heterogeneity, we performed comprehensive genomic analyses for 142 patients with childhood-onset mitochondrial respiratory chain complex deficiencies. The approach includes whole mtDNA and exome analyses using high-throughput sequencing, and chromosomal aberration analyses using high-density oligonucleotide arrays. We identified 37 novel mutations in known mitochondrial disease genes and 3 mitochondria-related genes (MRPS23, QRSL1, and PNPLA4) as novel causative genes. We also identified 2 genes known to cause monogenic diseases (MECP2 and TNNI3) and 3 chromosomal aberrations (6q24.3-q25.1, 17p12, and 22q11.21) as causes in this cohort. Our approaches enhance the ability to identify pathogenic gene mutations in patients with biochemically defined mitochondrial respiratory chain complex deficiencies in clinical settings. They also underscore clinical and genetic heterogeneity and will improve patient care of this complex disorder.


PLOS Genetics | 2010

Id4, a New Candidate Gene for Senile Osteoporosis, Acts as a Molecular Switch Promoting Osteoblast Differentiation

Yoshimi Tokuzawa; Ken Yagi; Yzumi Yamashita; Yutaka Nakachi; Itoshi Nikaido; Hidemasa Bono; Yuichi Ninomiya; Yukiko Kanesaki-Yatsuka; Masumi Akita; Hiromi Motegi; Shigeharu Wakana; Tetsuo Noda; Fred Sablitzky; Shigeki Arai; Riki Kurokawa; Toru Fukuda; Takenobu Katagiri; Christian Schönbach; Tatsuo Suda; Yosuke Mizuno; Yasushi Okazaki

Excessive accumulation of bone marrow adipocytes observed in senile osteoporosis or age-related osteopenia is caused by the unbalanced differentiation of MSCs into bone marrow adipocytes or osteoblasts. Several transcription factors are known to regulate the balance between adipocyte and osteoblast differentiation. However, the molecular mechanisms that regulate the balance between adipocyte and osteoblast differentiation in the bone marrow have yet to be elucidated. To identify candidate genes associated with senile osteoporosis, we performed genome-wide expression analyses of differentiating osteoblasts and adipocytes. Among transcription factors that were enriched in the early phase of differentiation, Id4 was identified as a key molecule affecting the differentiation of both cell types. Experiments using bone marrow-derived stromal cell line ST2 and Id4-deficient mice showed that lack of Id4 drastically reduces osteoblast differentiation and drives differentiation toward adipocytes. On the other hand knockdown of Id4 in adipogenic-induced ST2 cells increased the expression of Pparγ2, a master regulator of adipocyte differentiation. Similar results were observed in bone marrow cells of femur and tibia of Id4-deficient mice. However the effect of Id4 on Pparγ2 and adipocyte differentiation is unlikely to be of direct nature. The mechanism of Id4 promoting osteoblast differentiation is associated with the Id4-mediated release of Hes1 from Hes1-Hey2 complexes. Hes1 increases the stability and transcriptional activity of Runx2, a key molecule of osteoblast differentiation, which results in an enhanced osteoblast-specific gene expression. The new role of Id4 in promoting osteoblast differentiation renders it a target for preventing the onset of senile osteoporosis.


Cell Stem Cell | 2011

Indefinite Self-Renewal of ESCs through Myc/Max Transcriptional Complex-Independent Mechanisms

Tomoaki Hishida; Yuriko Nozaki; Yutaka Nakachi; Yosuke Mizuno; Yasushi Okazaki; Masatsugu Ema; Satoru Takahashi; Masazumi Nishimoto; Akihiko Okuda

Embryonic stem cells (ESCs) can self-renew indefinitely under the governance of ESC-specific transcriptional circuitries in which each transcriptional factor regulates distinct or overlapping sets of genes with other factors. c-Myc is a key player that is crucially involved in maintaining the undifferentiated state and the self-renewal of ESCs. However, the mechanism by which c-Myc helps preserve the ESC status is still poorly understood. Here we addressed this question by performing loss-of-function studies with the Max gene, which encodes the best-characterized partner protein for all Myc family proteins. Although Myc/Max complexes are widely regarded as crucial regulators of the ESC status, our data revealed that ESCs do not absolutely require these complexes in certain contexts and that this requirement is restricted to empirical ESC culture conditions without a MAPK inhibitor.


Allergology International | 2010

Curdlan Induces DC-Mediated Th17 Polarization via Jagged1 Activation in Human Dendritic Cells

Takehiro Higashi; Kumiko Hashimoto; Rie Takagi; Yosuke Mizuno; Yasushi Okazaki; Yoshiya Tanaka; Sho Matsushita

BACKGROUND Th17-inducing activity is carried by certain polysaccharides such as beta-glucan derived from Candia albicans. Our previous studies have shown that Th1- and Th2-inducing activities can be qualitatively evaluated by the expression patterns of Notch ligand isoforms, using human monocyte-derived dendritic cells (Mo-DCs) and some leukemic cell lines such as THP-1. The association of Th17-inducing activities with Notch ligand expression patterns has been unclear. METHODS Mo-DCs from healthy volunteers were co-cultured with HLA-DR-nonshared allogeneic CD4+ naïve T cells to induce a mixed lymphocyte reaction, in the presence of adjuvants, such as curdlan. Culture supernatants were assayed for IFNgamma, IL-5 and IL-17 by an enzyme-linked immunosorbent assay (ELISA). Notch ligand expression on Mo-DCs and THP-1 cells was evaluated by using RT-PCR. RESULTS The present study shows that curdlan, one of the beta-glucans, has the ability to induce DC-mediated Th17 differentiation. It is also interesting to note that Jagged1 mRNA in Mo-DCs and THP-1 cells is up-regulated by curdlan. Furthermore, polyclonal anti-Jagged1 antibody inhibited such DC-mediated Th17 differentiation. CONCLUSIONS This study suggests that curdlan induces human DC-mediated Th17 polarization via Jagged1 activation in DCs.


Stem Cells | 2009

Differential requirement for nucleostemin in embryonic stem cell and neural stem cell viability.

Jun Nomura; Masayoshi Maruyama; Miyuki Katano; Hidemasa Kato; Jiaxing Zhang; Shinji Masui; Yosuke Mizuno; Yasushi Okazaki; Masazumi Nishimoto; Akihiko Okuda

Stem cells have the remarkable ability to self‐renew and to generate multiple cell types. Nucleostemin is one of proteins that are enriched in many types of stem cells. Targeted deletion of nucleostemin in the mouse results in developmental arrest at the implantation stage, indicating that nucleostemin is crucial for early embryogenesis. However, the molecular basis of nucleostemin function in early mouse embryos remains largely unknown, and the role of nucleostemin in tissue stem cells has not been examined by gene targeting analyses due to the early embryonic lethality of nucleostemin null animals. To address these questions, we generated inducible nucleostemin null embryonic stem (ES) cells in which both alleles of nucleostemin are disrupted, but nucleostemin cDNA under the control of a tetracycline‐responsive transcriptional activator is introduced into the Rosa26 locus. We show that loss of nucleostemin results in reduced cell proliferation and increased apoptosis in both ES cells and ES cell‐derived neural stem/progenitor cells. The reduction in cell viability is much more profound in ES cells than in neural stem/progenitor cells, an effect that is mediated at least in part by increased induction and accumulation of p53 and/or activated caspase‐3 in ES cells than in neural stem/progenitor cells. Stem Cells 2009;27:1066–1076


PLOS Genetics | 2013

Tysnd1 Deficiency in Mice Interferes with the Peroxisomal Localization of PTS2 Enzymes, Causing Lipid Metabolic Abnormalities and Male Infertility

Yumi Mizuno; Yuichi Ninomiya; Yutaka Nakachi; Mioko Iseki; Hiroyasu Iwasa; Masumi Akita; Tohru Tsukui; Nobuyuki Shimozawa; Chizuru Ito; Kiyotaka Toshimori; Megumi Nishimukai; Hiroshi Hara; Ryouta Maeba; Tomoki Okazaki; Ali Al-Odaib; Mohammed Al Amoudi; Minnie Jacob; Fowzan S. Alkuraya; Yasushi Horai; Mitsuhiro Watanabe; Hiromi Motegi; Shigeharu Wakana; Tetsuo Noda; Igor V. Kurochkin; Yosuke Mizuno; Christian Schönbach; Yasushi Okazaki

Peroxisomes are subcellular organelles involved in lipid metabolic processes, including those of very-long-chain fatty acids and branched-chain fatty acids, among others. Peroxisome matrix proteins are synthesized in the cytoplasm. Targeting signals (PTS or peroxisomal targeting signal) at the C-terminus (PTS1) or N-terminus (PTS2) of peroxisomal matrix proteins mediate their import into the organelle. In the case of PTS2-containing proteins, the PTS2 signal is cleaved from the protein when transported into peroxisomes. The functional mechanism of PTS2 processing, however, is poorly understood. Previously we identified Tysnd1 (Trypsin domain containing 1) and biochemically characterized it as a peroxisomal cysteine endopeptidase that directly processes PTS2-containing prethiolase Acaa1 and PTS1-containing Acox1, Hsd17b4, and ScpX. The latter three enzymes are crucial components of the very-long-chain fatty acids β-oxidation pathway. To clarify the in vivo functions and physiological role of Tysnd1, we analyzed the phenotype of Tysnd1−/− mice. Male Tysnd1−/− mice are infertile, and the epididymal sperms lack the acrosomal cap. These phenotypic features are most likely the result of changes in the molecular species composition of choline and ethanolamine plasmalogens. Tysnd1−/− mice also developed liver dysfunctions when the phytanic acid precursor phytol was orally administered. Phyh and Agps are known PTS2-containing proteins, but were identified as novel Tysnd1 substrates. Loss of Tysnd1 interferes with the peroxisomal localization of Acaa1, Phyh, and Agps, which might cause the mild Zellweger syndrome spectrum-resembling phenotypes. Our data established that peroxisomal processing protease Tysnd1 is necessary to mediate the physiological functions of PTS2-containing substrates.


Stem Cells | 2012

Sirt1, p53, and p38MAPK Are Crucial Regulators of Detrimental Phenotypes of Embryonic Stem Cells with Max Expression Ablation†‡§

Tomoaki Hishida; Yuriko Nozaki; Yutaka Nakachi; Yosuke Mizuno; Hiroyoshi Iseki; Miyuki Katano; Masayoshi Kamon; Masataka Hirasaki; Masazumi Nishimoto; Yasushi Okazaki; Akihiko Okuda

c‐Myc participates in diverse cellular processes including cell cycle control, tumorigenic transformation, and reprogramming of somatic cells to induced pluripotent cells. c‐Myc is also an important regulator of self‐renewal and pluripotency of embryonic stem cells (ESCs). We recently demonstrated that loss of the Max gene, encoding the best characterized partner for all Myc family proteins, causes loss of the pluripotent state and extensive cell death in ESCs strictly in this order. However, the mechanisms and molecules that are responsible for these phenotypes remain largely obscure. Here, we show that Sirt1, p53, and p38MAPK are crucially involved in the detrimental phenotype of Max‐null ESCs. Moreover, our analyses revealed that these proteins are involved at varying levels to one another in the hierarchy of the pathway leading to cell death in Max‐null ESCs. STEM CELLS2012;30:1634–1644

Collaboration


Dive into the Yosuke Mizuno's collaboration.

Top Co-Authors

Avatar

Yasushi Okazaki

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Yutaka Nakachi

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Yoshimi Tokuzawa

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Akihiko Okuda

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Masakazu Kohda

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Shunsuke Tamaru

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Hiroko Harashima

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Yoshihito Kishita

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Kei Murayama

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Akira Ohtake

Saitama Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge